19 июня, 2020

PharmacoGenetics n.155 — 30 November 2022

SIF Societa’ Italiana di Farmacologia

FarmacoGenetica n.155 —

Oncology
Wide association study between NUDT15 polymorphisms and mercaptopurine tolerance in a Japanese paediatric cohort with acute lymphoblastic leukemia
Neuropsychiatry
Pharmacogenetics-guided administration of clozapine based on HLA-DQB1, HLA-B and SLCO1B3-SLCO1B7 variants
Immunomodulation
Pharmacogenomics of genes encoding for methotrexate pathway proteins in rheumatoid arthritis patients: an approach towards personalized medicine
Neonatology
Pharmacogenetics may explain some of the interindividual variability in the pharmacodynamic response to dobutamine administered in Newborn
The meta-analysis of the month
The GABRA1 rs2279020 and GABRA6 rs3219151 variants are not associated with susceptibility to epilepsy and clinical response to antiepileptic drugs in Asian and Arab patients

By reading the full articles:
https://www.sifweb.org/pubblicazioni/sif-farmacogenetica/sif-farmacogenetica-155-2022-11-30

— Reproduction reserved and for personal use
— Download the full document in PDF format from the link at the bottom of the page

Access to the site is limited and reserved for healthcare professionals

You have reached the maximum number of visits

Source — https://www.univadis.it/viewarticle/farmacogenetica-n155—30-novembre-2022

TAGS:
Comments are closed.